We have data to show that deficiency of perforin in CTLs resulted in significantly decrease in IL-1β level in GVHD target tissues as well as GVHD pathology, indicating that perforin is an important NLRP3 activator in GVHD model in vivo. Here, PRF1 is linked to graft versus host disease.